GI & Endoscopy

Here are five recent news updates on gastroenterology and endoscopy companies.

The FDA has released a safety warned focused on the use of hepatitis C treatments, such as Harvnoi or Sovaldi, taken with another direct acting antiviral and the antiarrhythmic drug amiodarone.

The global smart pills market is expected to reach a value of $8.98 billion by 2024, according to a MarketandMarkets report.

Gregory G. Ginsberg, MD, is the director of endoscopic services at Philadelphia-based Penn Medicine and is a professor of medicine and surgery at the Hospital of the University of Pennsylvania. He is a member of the American Gastroenterology Association, American…

Boston Scientific's price target was raised by Barclays from $19 to $20, according to a Sleek Money report.

Here are seven statistics on Match Day for GI in 2013, according to the American Gastroenterological Association.

Baptist Medical Center in Jacksonville, Fla., has acquired the Cellvizio technology platform for biliary and pancreatic disease care.

PENTAX Medical has named David Woods, previously the company's president of the Americas, its new chief marketing officer, effective April 1.

Charlevoix (Mich.) Area Hospital has added gastroenterologist Thomas Tietjen, MD, to its medical team, according to a Charlevoix Courier report.

Here are the five most read gastroenterology/endoscopy articles on Becker's ASC Review for the week of March 16 to March 20.